These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7707610)
21. US advisory panel revisits prison research rules. Loewenberg S Lancet; 2006 Sep; 368(9542):1143-4. PubMed ID: 17016874 [No Abstract] [Full Text] [Related]
22. An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy. Meinert CL Control Clin Trials; 1996 Aug; 17(4):273-84. PubMed ID: 8889342 [No Abstract] [Full Text] [Related]
23. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111 [TBL] [Abstract][Full Text] [Related]
25. Clevudine University of Georgia/Abbott/Bukwang/Triangle/Yale University. Kocic I Curr Opin Investig Drugs; 2000 Nov; 1(3):308-13. PubMed ID: 11249713 [TBL] [Abstract][Full Text] [Related]
26. IOM committee gazes into new vaccine future. Institute of Medicine. Marwick C JAMA; 1999 Apr; 281(15):1366-7. PubMed ID: 10217038 [No Abstract] [Full Text] [Related]
28. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs. Watabe T J Toxicol Sci; 1996 Dec; 21(5):299-300. PubMed ID: 9035040 [No Abstract] [Full Text] [Related]
29. Deaths bring clinical trials under scrutiny in Japan. Swinbanks D Nature; 1994 Jun; 369(6483):697. PubMed ID: 8008052 [No Abstract] [Full Text] [Related]
30. Proving nursing negligence. Lee NG Am J Nurs; 2000 Nov; 100(11):55-6. PubMed ID: 11103638 [No Abstract] [Full Text] [Related]
31. Deaths in US fialuridine trial. Brahams D Lancet; 1994 Jun; 343(8911):1494-5. PubMed ID: 7911188 [No Abstract] [Full Text] [Related]
32. The Institute of Medicine, the National Cancer Institute, and clinical trials. Cox JD Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1285-6. PubMed ID: 21414512 [No Abstract] [Full Text] [Related]
33. Researchers push back against overhauling clinical trials. Jenks S J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25122733 [No Abstract] [Full Text] [Related]
34. Panel backs pregnant women in trials. Anderson C Science; 1994 Mar; 263(5151):1216. PubMed ID: 8122099 [No Abstract] [Full Text] [Related]
35. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
36. IOM report calls for culture of data sharing. Cancer Discov; 2015 Mar; 5(3):219-20. PubMed ID: 25616854 [No Abstract] [Full Text] [Related]
37. Medical professional liability and obstetric care: the Institute of Medicine report and recommendations. Herbst AL Obstet Gynecol; 1990 Apr; 75(4):705-9. PubMed ID: 2314789 [No Abstract] [Full Text] [Related]
38. Clinical trials in the face of adversity. Clodfelter K J Biolaw Bus; 2002; 5(3):34-8. PubMed ID: 12816114 [TBL] [Abstract][Full Text] [Related]
39. The 2010 Institute of Medicine consensus statement "A national clinical trials network for the 21st century": progress and challenges. Mendelsohn J; Bertagnolli MM Semin Oncol; 2014 Aug; 41(4):435-436. PubMed ID: 25173135 [No Abstract] [Full Text] [Related]
40. Silence is not the best medicine: requiring disclosure of clinical trial data for abandoned drugs. Powell B J Leg Med; 2012 Oct; 33(4):571-92. PubMed ID: 23216153 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]